Anthony Hunt Repligen Corp (RGEN) insider trading activity

RGEN Quotes by TradingView

Anthony Hunt is of REPLIGEN CORP. Currently has a direct ownership of 109,854 shares of RGEN, which is worth approximately $13.6 Million. The most recent transaction as insider was on Feb 24, 2021, when has been sold 10,437 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
19.4% 3M change
33.49% 12M change
Total Value Held $13.6 Million

Anthony Hunt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2021
BUY
Grant, award, or other acquisition
-
10,437 Added 4.11%
243,764 Common Stock
Nov 19 2020
SELL
Open market or private sale
$3,722,400 $186.12 p/Share
20,000 Reduced 7.89%
233,327 Common Stock
Nov 19 2020
BUY
Exercise of conversion of derivative security
$521,000 $26.05 p/Share
20,000 Added 7.32%
253,327 Common Stock

Also insider at

MASS
908 Devices Inc. Healthcare
BLFS
BIOLIFE SOLUTIONS INC Healthcare
Director
AH

Anthony Hunt

Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGEN